Red Blood Cells Inspire Next-Generation Therapeutic Nanocarriers

Engineered red blood cell vesicles improve gene therapy delivery

Red blood cells serve as the foundation for nanocarriers that show promise in a new study as effective and efficient vehicles for gene therapy, tumor targeting and other medical treatments.

Gene Therapies-Sustaining Long-Term Follow-Up

Table of ContentsWhy Sustaining LTFU Cell Gene Therapy IQVIA Programs Is So DifficultThe Geographic Dispersion ProblemHow Patient-Centered Design Anchors LTFU Cell Gene Therapy IQVIA StrategyConcierge Services and Patient Advocacy PartnershipsEnriched Real-World Data Collection Within LTFU Cell Gene Therapy IQVIA MethodsWorking With Disease RegistriesDigital and Decentralized Tools Reducing Burden in LTFU Cell Gene Therapy IQVIA DesignMobile Nur…

Red Blood Cells Inspire Next-Generation Therapeutic Nanocarriers

Red blood cells serve as the foundation for nanocarriers that show promise in a new study as effective and efficient vehicles for gene therapy, tumor targeting and other medical treatments.

New Lipid Vesicles Evade Immune Cells to Target Cancer Tumors

Red blood cells serve as the foundation for nanocarriers that show promise in a new study as effective and efficient vehicles for gene therapy, tumor targeting and other medical treatments.

Virus-Like Particles Enable Targeted Gene Engineering and Pooled CRISPR Screening in Primary Human Myeloid Cells

Investigators presented a virus-like particle-based toolkit that delivers diverse CRISPR editing modalities to human monocytes, macrophages and dendritic cells with high efficiency while preserving viability and innate immune responsiveness. [Nature Biotechnology] Abstract